List your tool

Head to head · 2026

Artera vs Narrativa

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Artera

FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions

4.4Not listed

Visit Artera (opens Artera in a new tab)

Narrativa

Agentic AI generates compliant clinical study reports, patient narratives, and regulatory submissions at scale - GxP-ready,…

3.6Not listed

Visit Narrativa (opens Narrativa in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Artera does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Artera

    4.4 against 3.6

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onArteraNarrativa
Our rating4.4Better3.6
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Multimodal AI trained on digitized biopsy images paired with clinical data
  • FDA De Novo authorization for the ArteraAI Prostate Test
  • FDA clearance for ArteraAI Breast digital pathology risk stratification
  • Results delivered in as little as two days after sample submission
  • Inclusion in National Comprehensive Cancer Network (NCCN) treatment guidelines
  • Agentic AI generates clinical study reports and patient narratives
  • Knowledge graph technology for complex clinical relationships
  • GxP-ready validation architecture
  • GDPR-aligned and HIPAA-ready data handling
  • Risk-based AI safety framework aligned with FDA/EMA guidance
Pros
  • Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups
  • Published clinical evidence showing improved outcome prediction versus existing risk models
  • Adopted by a meaningful share of US prostate cancer clinicians already
  • Purpose-built compliance architecture (GxP/FDA/EMA-aligned), not generic enterprise AI
  • Covers the full documentation chain from clinical data through regulatory submission
  • Knowledge graph approach suits the complex, interlinked nature of clinical data
Cons
  • Not a self-serve software product; access runs through labs, clinicians, and insurance billing
  • Pricing is not public and varies by payer and region
  • Limited to prostate and breast cancer currently, not a general oncology platform
  • No published pricing - an enterprise sales process
  • Built specifically for regulated life sciences, not a general documentation tool
  • High-stakes regulatory output still requires expert human review before submission
CompanyArtera, founded 2021Narrativa

Prices come from each vendor's pricing page, last checked 20260826. Check the vendor before you buy.

FAQ

Questions people ask

Is Artera better than Narrativa?

In our reviews Artera scores 4.4 and Narrativa scores 3.6. The better pick depends on the job. Artera: FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions. Narrativa: Agentic AI generates compliant clinical study reports, patient narratives, and regulatory submissions at scale - GxP-ready, GDPR-aligned, and built to an FDA/EMA-aligned safety framework.

Which is cheaper, Artera or Narrativa?

Artera: see pricing. Narrativa: see pricing.

Do Artera and Narrativa have free plans?

Neither lists a free plan.

More comparisons

Artera compared with

All Artera alternatives

Narrativa compared with

All Narrativa alternatives